Abstract
Cyclosporine (CyA) has made a great impact on 1-year allograft survival, however, after years, renal function deteriorates, possibly due to chronic toxicity. Recently, Mycophenolate mofetil (MMF) was introduced as a non-nephrotoxic immunosuppressant that might be effective in chronical transplant arteriolopathy. We therefore started MMF at a dose of 600 mg/m2 b. i. d. in 18 pediatric renal transplant recipients (10.8 ± 3.9 (SD) years of age at transplantation, 11/18 with a history of rejections) with biopsy-proven chronic arteriolopathy and other signs of CyA toxicity at a mean follow up time of 6.2 ± 2.7 (range 2.3–11.8) years after transplantation. One month prior to conversion, mean serum creatinine was 171 ± 96 μmol/l, lower than at the time of conversion (188 ± 100 μmol/l, P = 0.003, paired t-test). At last follow-up (median 13.7 months, range 5.0 to 25.0 months) after conversion, mean serum creatinine decreased significantly to 127 ± 69 μmol/l (P = 0,0003, paired t-test). The CyA dosage was reduced from a mean of 150 ± 39 mg/m2 per day to 59 ± 13 mg/m2 per day in 7 patients, and CyA was discontinued in 11 patients after a median period of nine months (range 1–18 months). After a median period of 21 days, a pharmacokinetic profile was performed in all patients. The mean MMF dose was 1117 ± 319 mg/m2 per day (range 675–1774 mg/m2 per day). The mean Mycophenolic acid (MPA) trough concentration was 4.0 ± 2.0 μg/ml, range 1.4–7.9 μg/ml. Mean 12 h MPA AUC was 70.6 ± 28.1 (range 31.9–127) μg × h/ml. Except for one patient with diarrhea associated with a high AUC, and for one patient with a steroid-sensitive rejection episode after 566 days, no other patient experienced side effects or a rejection episode. Prednisolone was left unaltered at 2–4 mg/m2 per day. We conclude that MMF allows safe reduction of CyA with markedly better graft function, suggesting that chronical CyA-toxicity partially accounts for deteriorating allograft function.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 20 April 1999 Revised: 9 January 2000 Accepted: 15 March 2000
About this article
Cite this article
Filler, G., Gellermann, J., Zimmering, M. et al. Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity. Transpl Int 13, 201–206 (2000). https://doi.org/10.1007/s001470050687
Issue Date:
DOI: https://doi.org/10.1007/s001470050687